Feedback / Questions
Revascor (rexlemestrocel-L) - Mesoblast, Grunenthal
https://www.globenewswire.com/news-release/2025/06/12/3098012/0/en/Mesoblast-Maintains-Momentum-With-FDA-on-Accelerated-Approval-Pathway-for-Revascor-in-Ischemic-Heart-Failure-and-Label-Extension-for-Ryoncil-in-Adults-With-GvHD.html
Jun 11, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next